Your browser doesn't support javascript.
loading
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax.
Lin, Victor S; Lew, Thomas E; Handunnetti, Sasanka M; Blombery, Piers; Nguyen, Tamia; Westerman, David A; Kuss, Bryone J; Tam, Constantine S; Roberts, Andrew W; Seymour, John F; Anderson, Mary Ann.
Afiliación
  • Lin VS; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Lew TE; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Handunnetti SM; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Blombery P; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Nguyen T; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Westerman DA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Kuss BJ; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Tam CS; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
  • Roberts AW; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Seymour JF; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Anderson MA; Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Blood ; 135(25): 2266-2270, 2020 06 18.
Article en En | MEDLINE | ID: mdl-32244251

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Pirimidinas / Sulfonamidas / Adenina / Leucemia Linfocítica Crónica de Células B / Terapia Recuperativa / Compuestos Bicíclicos Heterocíclicos con Puentes / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Pirazoles / Pirimidinas / Sulfonamidas / Adenina / Leucemia Linfocítica Crónica de Células B / Terapia Recuperativa / Compuestos Bicíclicos Heterocíclicos con Puentes / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2020 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos